Excellent.
Looks like AMP945 could enhance more than one standard of care chemo treatment.
If successful, big pharma wil wrap this up quickly then license its use across the board.
Holding........plenty.
Ann: AMP945 and FOLFIRINOX active in model of Pancreatic Cancer, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
-0.005(3.70%) |
Mkt cap ! $35.64M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $23.48K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 328289 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 77366 | 3 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| ATX (ASX) Chart |